Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Multimorbidity Phenotypes and Effects on Endothelium in Critically Ill Patients with Sepsis and Sepsis-induced ARDS

Award Number: F32HL179891
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 02/01/2026
PERIOD OF PERFORMANCE END DATE: 01/31/2027
AWARD TERMINATION DATE: 03/30/2026

Group Awards By:

View Award Description

Multimorbidity Phenotypes and Effects on Endothelium in Critically Ill Patients with Sepsis and Sepsis-induced ARDS - Project Summary / Abstract Acute respiratory distress syndrome (ARDS) is a common, costly, and often fatal inflammatory lung injury with an in-hospital mortality rate exceeding 40%. The leading cause is sepsis, termed sepsis-induced ARDS (si- ARDS). The incidence of ARDS spikes during bacterial and viral outbreaks, such as the H1N1 and COVID-19 pandemics. Chronic comorbidities, particularly metabolic syndrome (MetS), are independently associated with increased ARDS severity, highlighting a critical gap in understanding and managing these patients. This project aims to address the research gap surrounding multimorbidity and its effects on si-ARDS via endothelial-extracellular vesicle (EV) dysregulation. Our central hypothesis is that patients' baseline comorbidities influence EV intercellular cargo, which in turn affects the pulmonary endothelial cell (EC) response in si-ARDS, explaining clinical heterogeneity. The long-term goal is to define ICU subphenotypes based on multimorbidity status and explore how chronic conditions affect the endothelial-EV response to septic insults and lung injury to inform novel therapeutic strategies. We will leverage the Sepsis ECMO and ARDS (SEA) biorepository, an established biobank at Rhode Island Hospital's medical ICU, with over 260 participants enrolled. The study aims to validate preliminary observations in a larger, more diverse cohort of participants while isolating EVs for mechanistic experiments. We propose to: Aim 1: Identify subphenotypes of sepsis and si-ARDS participants based on chronic comorbidities via unsupervised cluster analysis and test each subphenotype's associations with clinical outcomes such as si- ARDS development and severity, mechanical ventilation, ICU length of stay, and in-hospital mortality. Aim 2: Determine and compare how EVs isolated from si-ARDS subphenotypes affect EC function. Aim 2a: Characterize and compare isolated EVs by cellular origin, then co-incubate EVs with naïve human pulmonary microvascular ECs and perform EC function assays. Aim 2b: Conduct mediation analysis to determine what portion of the observed risk between si-ARDS subphenotypes and clinical outcomes is mediated by EV-EC interaction. This innovative approach aims to phenotype sepsis and si-ARDS patients based on naturally co-occurring comorbidity clusters and unravel EV-EC interactions driving these subphenotypes, providing critical insights for precision-based treatments and preparing for future pandemics.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = -$92,464 )
2026	2025	RHODE ISLAND HOSPITAL	593 EDDY ST	PROVIDENCE	RI	02903	PROVIDENCE	USA	Lung Diseases Research	000	1	3/30/2026	TERMINATION	-$92,464
														Subtotal = -$92,464

Issue Date FY: 2025 ( Subtotal = $92,464 )
2025	2025	RHODE ISLAND HOSPITAL	593 EDDY ST	PROVIDENCE	RI	02903	PROVIDENCE	USA	Lung Diseases Research	000	1	8/18/2025	NEW	$92,464
														Subtotal = $92,464

Grand Total All Awards = $0

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Multimorbidity Phenotypes and Effects on Endothelium in Critically Ill Patients with Sepsis and Sepsis-induced ARDS

Award Number: F32HL179891

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 02/01/2026

PERIOD OF PERFORMANCE END DATE: 01/31/2027

AWARD TERMINATION DATE: 03/30/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer